Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Pulm Med ; 22(1): 87, 2022 Mar 15.
Article in English | MEDLINE | ID: mdl-35291989

ABSTRACT

BACKGROUND: Dexmedetomidine (DEX), is a highly selective alpha2 adrenoceptor (α2-AR) agonist, successfully used in various procedures including flexible bronchoscopy. Randomized controlled trials (RCTs) evaluating DEX sedation during bronchoscopy report equivocal results regarding respiratory and hemodynamic outcomes. METHODS: We conducted an RCT to evaluate the efficacy and safety of dexmedetomidine compared to propofol for sedation during bronchoscopy. The primary outcome was the number of desaturation events, secondary outcomes were transcutaneous Pco2 level, hemodynamic adverse events and physician and patient satisfaction. RESULTS: Overall, 63 patients were included, 30 and 33 in the DEX and propofol groups, respectively. The number of desaturation events was similar between groups, median (IQR) 1 (0-1) and 1 (0-2) in the DEX and control groups, respectively (P = 0.29). Median desaturation time was 1 (0-2) and 1 (0-3) minutes in the DEX and control groups, respectively (P = 0.48). Adverse events included hypotension, 33% vs 21.1% in intervention and control groups, respectively (P = 0.04), bradycardia, cough, and delayed recovery from sedation. Total adverse events were 22 and 7 in DEX and propofol groups, respectively (P = 0.009). CONCLUSION: Dexmedetomidine sedation during bronchoscopy did not show differences in oxygen saturation and transcutaneous CO2 level in comparison to propofol. Moreover, DEX sedation required a significantly higher number of rescue boluses, due to inadequate sedation and was associated with a higher rate of adverse events. Trial registration NCT04211298, registration date: 26.12.2019.


Subject(s)
Dexmedetomidine , Propofol , Bronchoscopy/adverse effects , Bronchoscopy/methods , Conscious Sedation/methods , Dexmedetomidine/adverse effects , Humans , Hypnotics and Sedatives/adverse effects , Propofol/adverse effects
2.
Ultrason Sonochem ; 21(6): 2112-6, 2014 Nov.
Article in English | MEDLINE | ID: mdl-24704066

ABSTRACT

In food industry, conventional methodologies such as grinding, mixing, and heat treatment are used for food processing and preservation. These processes have been well studied for many centuries and used in the conversion of raw food materials to consumable food products. This report is dedicated to the application of a cost-efficient method of energy transfer caused by acoustic cavitation effects in food processing, overall, having significant impacts on the development of relatively new area of food processing such as food sonochemistry.


Subject(s)
Food-Processing Industry/methods , Ultrasonics/methods , Animals , Cost-Benefit Analysis , Energy Transfer , Food-Processing Industry/economics , Hydrogen Bonding , Meat , Milk/chemistry , Models, Molecular , Molecular Conformation , Russia , Ultrasonics/economics , Water/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...